Immediate Impact
2 standout
Citing Papers
Therapeutic advances of targeting receptor tyrosine kinases in cancer
2024 Standout
Works of Matthew Still being referenced
Tyrosine Phosphatase PTPRO Deficiency in ERBB2-Positive Breast Cancer Contributes to Poor Prognosis and Lapatinib Resistance
2022
Author Peers
| Author | Last Decade | Papers | Cites | |||||
|---|---|---|---|---|---|---|---|---|
| Matthew Still | 11 | 7 | 3 | 15 | 12 | 2 | 31 | |
| Writaja Halder | 7 | 12 | 6 | 11 | 5 | 2 | 29 | |
| Ronald Rentsch | 36 | 4 | 3 | 11 | 4 | 2 | 50 | |
| Eskil Kreiner | 10 | 18 | 5 | 4 | 41 | 3 | 43 | |
| Tala Dajani | 8 | 43 | 11 | 9 | 4 | 182 | ||
| D Johnston | 15 | 2 | 13 | 2 | 3 | 28 | ||
| Yuan Yu | 12 | 9 | 2 | 12 | 2 | 27 | ||
| Deborah Beeby | 6 | 3 | 7 | 2 | 7 | 2 | 24 | |
| Angelo Maria Minnella | 9 | 66 | 1 | 6 | 5 | 4 | 164 | |
| S. M. Wood | 12 | 18 | 10 | 7 | 10 | 5 | 164 | |
| S Boussedra | 10 | 10 | 2 | 6 | 4 | 34 |
All Works
Login with ORCID to disown or claim papers
Loading papers...